HIGHLIGHTS
- who: Hodaka Yamada from the Department of Endocrinology and Metabolism, Jichi Medical University Saitama Medical Center, u2011847, Amanumau2011cho, Omiyau2011ku, Saitama, u20118503, Japan have published the paper: Hypereosinophilia is a predictive biomarker of immune checkpoint inhibitor-induced hypopituitarism in patients with renal cell carcinoma, in the Journal: (JOURNAL)
- what: This study aimed to evaluate whether hypereosinophilia can be used as a useful early clinical biomarker of ICI-induced hypopituitarism in patients with RCC. Based on the study , the authors propose that if clinical symptoms are absent, ACTH and cortisol levels should be checked in patients with . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.